ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
ARTRYA ORD
$5.000
$0.020 (0.40%)
Day Range
$4.900 - $5.090
52 Week Range
$0.605 - $5.240
Volume
310.16K
Avg Volume (10D)
419.16K
Market Cap
$799.00M
Price Chart
Market Statistics
Open$4.980
Previous Close$5.020
Day High$5.090
Day Low$4.900
52 Week High$5.240
52 Week Low$0.605
Valuation
Market Cap799.00M
Shares Outstanding159.80M
Price to Book8.51
Trading Activity
Volume310.16K
Value Traded1.55M
Bid$4.990 × 41
Ask$5.000 × 7,119
Performance
1 Day-0.62%
5 Day9.57%
13 Week35.11%
52 Week563.45%
YTD2.12%
Technical Indicators
RSI (14)69.79
50-Day SMA$3.760
200-Day SMA$3.230
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
1 min read
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]
3 min read
